Treatment Algorithm for Metastatic Non–Small Cell Lung Cancer (NSCLC)

home / treatment-algorithms-with-the-oncology-brothers / treatment-algorithm-for-metastatic-non-small-cell-lung-cancer-nsclc

Isabel Preeshagul, DO, MBS, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, for a comprehensive discussion on the treatment of patients with metastatic non–small cell lung cancer who have no actionable mutations in the first-line setting.

Isabel Preeshagul, DO, MBS, with the Oncology Brothers presenting slides

EP. 1: Treating Newly Diagnosed Metastatic NSCLC with No Actionable Mutations in the First Line

Rahul Gosain, MD;Rohit Gosain, MD;Isabel Preeshagul, DO, MBS
July 25th 2024

Isabel Preeshagul, DO, MBS, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss treatment practices for newly diagnosed patients with metastatic non–small cell lung cancer (NSCLC) and no actionable mutations.

Isabel Preeshagul, DO, MBS, with the Oncology Brothers presenting slides

EP. 2: Dual Checkpoint Inhibitors with Chemotherapy in Metastatic NSCLC

Rahul Gosain, MD;Rohit Gosain, MD;Isabel Preeshagul, DO, MBS
July 25th 2024

Medical oncologists discuss the role of dual checkpoint inhibitors with chemotherapy in the treatment of patients with metastatic non–small cell lung cancer.

Isabel Preeshagul, DO, MBS, with the Oncology Brothers presenting slides

EP. 3: Treating Patients with NSCLC and Actionable Mutations Following Progression

Rahul Gosain, MD;Rohit Gosain, MD;Isabel Preeshagul, DO, MBS
July 25th 2024

Isabel Preeshagul, DO, MBS, and the Oncology Brothers discuss the treatment of patients with NSCLC and actionable mutations following progression on first-line therapy.

Isabel Preeshagul, DO, MBS, with the Oncology Brothers presenting slides

EP. 4: Later-Line Treatment of Patients with Metastatic NSCLC

Rahul Gosain, MD;Rohit Gosain, MD;Isabel Preeshagul, DO, MBS
July 25th 2024

The Oncology Brothers and Isabel Preeshagul, DO, MBS, share clinical insights on later-line treatment practices for patients with metastatic non–small cell lung cancer.